Provided by Tiger Trade Technology Pte. Ltd.

Viatris Inc.

16.32
+0.32002.00%
Post-market: 16.00-0.3200-1.96%19:30 EDT
Volume:6.49M
Turnover:105.62M
Market Cap:18.75B
PE:-46.06
High:16.37
Open:16.01
Low:15.98
Close:16.00
52wk High:18.39
52wk Low:9.43
Shares:1.15B
Float Shares:1.14B
Volume Ratio:0.90
T/O Rate:0.57%
Dividend:0.48
Dividend Rate:2.94%
EPS(TTM):-0.3543
EPS(LYR):-3.0024
ROE:-2.75%
ROA:2.67%
PB:1.31
PE(LYR):-5.44

Loading ...

Viatris - Vr-205 Meets Primary and Key Secondary Endpoints and is Well Tolerated

THOMSON REUTERS
·
Jun 29

Viatris Announces Positive Top-line Results from Phase 3 Study of Vr-205 in Japanese Adults with Primary Immunoglobulin a Nephropathy

THOMSON REUTERS
·
Jun 29

Viatris - Vr-205 Shows 33.75% Reduction in Upcr at 9 Months in Phase 3 Study

THOMSON REUTERS
·
Jun 29

Viatris Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Jun 27

Viatris Interim CFO Paul Campbell Sells 50,076 Shares for $809,927.6

Reuters
·
Jun 27

How Viatris’ €650 Million Eurobond Issue (VTRS) Has Changed Its Investment Story

Simply Wall St.
·
Jun 24

Viatris Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Jun 24

FDA Seeks Updated Labeling for Testosterone Therapies

MT Newswires Live
·
Jun 19

Viatris Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Jun 19

Viatris prices EUR 650 million 4.25% senior notes due 2033

Reuters
·
Jun 19

Viatris Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 18

Viatris Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
Jun 17

Viatris prices EUR 650 million 4.25% senior notes due 2033

Reuters
·
Jun 16

Euro Bond Sale Might Change The Case For Investing In Viatris (VTRS)

Simply Wall St.
·
Jun 16

Viatris Prices Offering of €650 Mln of 4.250% Senior Notes Due 2033 - SEC Filing

THOMSON REUTERS
·
Jun 13

Viatris Inc: Files for Euro Denominated Notes Offering, Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Jun 12

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jun 12

Australia's Therapeutic Goods Administration: Viatris Notified US Supply Constraints Affecting Creon 25,000 Unit and Creon 35,000 Unit Capsules Will Continue Until Jan 31, 2027

THOMSON REUTERS
·
Jun 11

Australia's Tga: Supply Constraints Affecting Creon Units Due to an Unexpected Global Increase in Demand

THOMSON REUTERS
·
Jun 11

Australia's Tga: Viatris Will Continue to Receive Regular Supplies of All Strengths of Creon in Australia; Availability May Be Limited

THOMSON REUTERS
·
Jun 11